Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Ross

Showing results (71-80 of 128) with videos related to

Pageof 13
Sort By:
BMC Public Health|September 19, 2023
Experiences of stigma and HIV care engagement in the context of Treat All in Rwanda: a qualitative studyCharles Ingabire, Dana Watnick, Josephine Gasana, et al.
Cell Chemical Biology|September 4, 2018
Selenocysteine-Specific Mass Spectrometry Reveals Tissue-Distinct Selenoproteomes and Candidate SelenoproteinsLin Guo, Wu Yang, Qiang Huang, et al.
Global Public Health|August 8, 2022
Challenges and best practices for hepatitis C care among people who inject drugs in resource limited settings: focus group discussions with healthcare providers in KenyaRie Seu, Lindsey R Riback, Mercy Nyakowa, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 31, 2025
Not a Monolith: Regional HIV Implementation Science Lessons With Latino/a/x PopulationsHarita S Shah, Pedro Alonso Serrano, Carlos E Rodriguez-Diaz, et al.
Plos One|December 2, 2020
Knowledge, attitudes, and acceptability of direct-acting antiviral hepatitis C treatment among people incarcerated in jail: A qualitative studyMatthew J Akiyama, Jonathan Ross, Fatimah Rimawi, et al.
Expert Opinion on Emerging Drugs|March 28, 2022
Epilepsy: expert opinion on emerging drugs in phase 2/3 clinical trialsAmanda W Pong, Jonathan Ross, Ivana Tyrlikova, et al.
Journal of Cannabis Research|March 28, 2023
"It doesn't make any sense to even try": the disruptive impact of COVID-19's first wave on people with chronic pain using medical cannabis in New YorkYuval Zolotov, Jacinta Lomba, Megan Ghiroli, et al.
International Journal of STD & AIDS|February 13, 2018
Highlighting the clinical need for diagnosing Mycoplasma genitalium infectionCatherine A Ison, Helen Fifer, Simon Gwynn, et al.
Research Square|February 6, 2026
Community-engaged research in HIV implementation science: A cross-sectional assessment of meaningful engagement among community and academic recipients of 2021 and 2022 'ending the HIV epidemic' supplement awardsReva Datar, Wilson Gomez, Sheree Schwartz, et al.
Journal of the International AIDS Society|June 15, 2020
High levels of viral load monitoring and viral suppression under Treat All in Rwanda - a cross-sectional studyJonathan Ross, Muhayimpundu Ribakare, Eric Remera, et al.
Pageof 13

Showing results (71-80 of 128) with videos related to

Sort By:
Pageof 13
BMC Public Health|September 19, 2023
Experiences of stigma and HIV care engagement in the context of Treat All in Rwanda: a qualitative studyCharles Ingabire, Dana Watnick, Josephine Gasana, et al.
Cell Chemical Biology|September 4, 2018
Selenocysteine-Specific Mass Spectrometry Reveals Tissue-Distinct Selenoproteomes and Candidate SelenoproteinsLin Guo, Wu Yang, Qiang Huang, et al.
Global Public Health|August 8, 2022
Challenges and best practices for hepatitis C care among people who inject drugs in resource limited settings: focus group discussions with healthcare providers in KenyaRie Seu, Lindsey R Riback, Mercy Nyakowa, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 31, 2025
Not a Monolith: Regional HIV Implementation Science Lessons With Latino/a/x PopulationsHarita S Shah, Pedro Alonso Serrano, Carlos E Rodriguez-Diaz, et al.
Plos One|December 2, 2020
Knowledge, attitudes, and acceptability of direct-acting antiviral hepatitis C treatment among people incarcerated in jail: A qualitative studyMatthew J Akiyama, Jonathan Ross, Fatimah Rimawi, et al.
Expert Opinion on Emerging Drugs|March 28, 2022
Epilepsy: expert opinion on emerging drugs in phase 2/3 clinical trialsAmanda W Pong, Jonathan Ross, Ivana Tyrlikova, et al.
Journal of Cannabis Research|March 28, 2023
"It doesn't make any sense to even try": the disruptive impact of COVID-19's first wave on people with chronic pain using medical cannabis in New YorkYuval Zolotov, Jacinta Lomba, Megan Ghiroli, et al.
International Journal of STD & AIDS|February 13, 2018
Highlighting the clinical need for diagnosing Mycoplasma genitalium infectionCatherine A Ison, Helen Fifer, Simon Gwynn, et al.
Research Square|February 6, 2026
Community-engaged research in HIV implementation science: A cross-sectional assessment of meaningful engagement among community and academic recipients of 2021 and 2022 'ending the HIV epidemic' supplement awardsReva Datar, Wilson Gomez, Sheree Schwartz, et al.
Journal of the International AIDS Society|June 15, 2020
High levels of viral load monitoring and viral suppression under Treat All in Rwanda - a cross-sectional studyJonathan Ross, Muhayimpundu Ribakare, Eric Remera, et al.
Pageof 13